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YsrH is a novel cis-encoded sRNA located on the opposite strand to fabH2, which is essential for fatty
acid biosynthesis in bacteria. In this study, YsrH-mediated regulation of fabH2 expression was inves-
tigated in Yersinia pseudotuberculosis. Constitutive and inducible over-expression of YsrH decreased
the mRNA level of fabH2, while expression of downstream fabD and fabG remained unaffected. Poly-
nucleotide phosphorylase (PNPase) also played an important role in this regulation process by medi-
ating YsrH decay in the exponential phase. Thus, our data deﬁnes a cis-encoded sRNA that regulates
fatty acid synthesis via a regulatory mechanism also involving PNPase.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Fatty acids are essential components of cell membranes and are
also important sources of metabolic energy in all organisms [1].
Thus, fatty acid biosynthesis and degradation pathways are gener-
ally highly conserved and coordinately regulated tomaintainmem-
brane lipid homeostasis [1]. In bacteria, fatty acid biosynthesis is a
type II, or disassociated-enzyme system, where each of the reac-
tions of the pathway is catalyzed by a discrete cytoplasmic enzyme
[1,2]. Hence, the pathway consists of a collection of individual pro-
teins encoded by unique genes [3]. Studies have revealed that fatty
acid synthesis is initiated by b-ketoacyl-ACP synthase III, a product
of the fabH gene, which is universally found in both Gram-negative
and Gram-positive bacteria [3,4]. Furthermore, some chemical
compounds have been shown to inhibit FabH from diversemicroor-
ganisms, including multi-drug resistant bacterial pathogens [5].
This suggests that FabH represents an effective molecular target
for the development of new antimicrobial agents [5].
During the past decade, it has become evident that small non-
coding RNAs (sRNAs) serve essential regulatory mechanisms in
both eukaryotic and prokaryotic cells. In bacteria, sRNA-mediated
regulation impacts on a wide range of physiological processes,
including outer membrane biogenesis [6], sugar stress and metab-
olism [7] and pathogenesis [8]. Most identiﬁed sRNAs act throughpost-transcriptional regulation of mRNAs via base-pairing interac-
tions [9,10]. These sRNAs can be divided into two categories that
are referred to as cis-encoded and trans-encoded sRNAs [9,10].
To date the majority of sRNAs are trans-encoded, and these reg-
ulate target mRNAs via imperfect base-pairing [10–12]. Most trans-
encoded sRNAs repress their target mRNAs through blocking the
ribosome binding site (RBS) to inhibit translation initiation and/
or reduce target mRNA stability [10,13,14]. Additionally, the RNA
chaperone Hfq is often involved in trans-encoded sRNA-mediated
regulation in Gram-negative bacteria [10]. In contrast, cis-encoded
sRNAs are transcribed from the opposite DNA strand to their target
mRNAs [15]. Consequently, they share extended regions of com-
plete complementarity with their targets [15]. The known regula-
tory mechanisms employed by cis-encoded antisense sRNAs
include transcription attenuation, translation inhibition, inhibition
of primer maturation, and promotion or inhibition of mRNA degra-
dation [15,16].
Duplexes of trans-encoded sRNA-mRNA are often degraded by
endoribonucleases (endoRNases) such as RNase E or RNase III
[13,17]. RNase E is an important endoRNase responsible for the pro-
cessing and degradation of RNAs. Speciﬁcally, its C-terminal region
binds to polynucleotide phosphorylase (PNPase), RNA helicase B
and enolase to form the RNA degradosome that is responsible for
degradation of mRNAs [18,19]. RNase E also forms ribonucleopro-
tein complexes with Hfq/sRNAs through its C-terminal scaffold
region, which could actively recruit sRNAs to their target mRNAs
[13,19]. RNase III is another endoRNase involved both in
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tion [15,20], although the detailedmechanisms for this have not yet
been elucidated.
Several exoribonucleases are also responsible for trans-encoded
sRNA-mediated target mRNAs instability. For example, PNPase is a
30–50 exoribonuclease which degrades single-stranded RNA and
directly binds to Hfq [19,21]. Although PNPase binds to the
C-terminal scaffold region of RNase E to form RNA degradosome to
induce RNA decay, it can also inﬂuence the stability of sRNAs such
as MicA and RybB in a degradosome-independent manner [22].
PNPase is also responsible for trans-encoded sRNA turn-over for
which the mechanism is still unclear [23].
Using a cDNA cloning approach, a previous study identiﬁed 25
cis-encoded sRNAs in the plague bacilli Yersinia pestis [24]. Among
these sRNAs, Yp-sR16 (Yersinia sRNA regulator of fabH2, YsrH) is a
cis-encoded sRNA conserved in all Yersinia species [24]. YsrH is 64
nucleotides in length and is transcribed on the opposite strand
from fabH2, which encodes b-ketoacyl-acyl carrier protein
synthase III that is essential for bacterial fatty acid synthesis [24].
In this study, we investigated the regulatory role of YsrH on the
expression of fabH2 in the food-borne pathogen Yersinia
pseudotuberculosis.
2. Materials and methods
2.1. Bacterial strains, plasmids, growth media and oligonucleotides
Bacterial strains and plasmids used in this study are summa-
rized in Table S1. Escherichia coli strains were routinely grown in
Luria Bertani (LB) broth at 37 C. Y. pseudotuberculosis YPIII strains
were grown at 28 C in Yersinia–Luria–Bertani (YLB) medium (1%
tryptone, 0.5% yeast extract, 0.5% NaCl). When appropriate, antibi-
otics were added at the following concentrations: 100 lg ml1
ampicillin, 50 lg ml1 kanamycin, 30 lg ml1 chloramphenicol
and 15 lg ml1 nalidixic acid. Sequences of all oligonucleotides
used in this study are listed in Table S2.
2.2. Constitutive and inducible expression of YsrH
To constitutively over-express YsrH, a plasmid named pRO-
YsrH was constructed with an approach described previously
[25]. Brieﬂy, the ysrH gene encompassing both its transcriptional
start site and 30 bp downstream of the transcriptional terminator
identiﬁed by a stretch of T’s was PCR-ampliﬁed from YPIII-derived
genomic DNA using primers PLO-83/PLO-84 (Table S2). Similarly,
the primers PLO-163/PLO-194 were used to amplify a DNA frag-
ment representing anti-antisense ysrH from its terminator T-
stretch to the start site, this plasmid was named pRO-YsrHas. A
control vector named pRO100 was constructed based on the
pMD 18-T Vector (TaKaRa) as described previously [25]. The vector
backbone containing the PLlacO promoter (from the position-1),
ampicillin resistance cassette, pUC replicon and a strong rrnB ter-
minator was PCR-ampliﬁed with primers pRO-514EF/pRO-146R
(Table S2), digested with EcoRI and self-ligated to obtain pRO100.
The ysrH gene ampliﬁed with primers PLO-144/PLO-145 was
cloned into pBAD22 to give the L-arabinose inducible YsrH con-
struct pBAD-YsrH. L-Arabinose was added at a ﬁnal concentration
of 0.2% (w/v) to induce YsrH expression.
2.3. Mutant construction
The pnp deletion mutant (Dpnp) was constructed as described
previously [26]. Primers PLO-39/PLO-40 and PLO-41/PLO-17
(Table S2) were used to amplify the upstream and downstream
fragments of the pnp gene. The mutants Drnb, Drnr and rne701were constructed by the k Red recombinase one-step inactivation
method using pKD4 [27] as template DNA in combination with
the respective primer pairs: PLO-52/PLO-53, PLO-54/PLO-55 and
PLO-48/PLO-49 (Table S2). In strain rne701, the nucleotides
2103–3651 of the rne gene were replaced by the kanamycin resis-
tance cassette. All mutants were conﬁrmed by a combination of
PCR and sequencing.
2.4. RNA preparation and Northern blot
RNA preparation was performed essentially as previously
described [25], but with some slight modiﬁcations. Overnight cul-
tures of the different YPIII strains were diluted (1:100) in fresh
medium and grown to the indicated cell densities (OD600). Culture
aliquots were removed and mixed with 0.2 volume of the stop
solution (95% ethanol, 5% water-saturated phenol) and immedi-
ately frozen in liquid nitrogen. RNA was extracted using TRIzol
reagent (Invitrogen).
Following denaturation at 95 C for 5 min followed by a further
5 min on ice, the RNA samples (10 lg) were loaded onto 7 M urea/
6% polyacrylamide gels and transferred to positively charged Nylon
membranes (Roche). After UV-crosslinking and pre-hybridization of
the membranes in PerfectHyb™ plus Hybridization Buffer (Sigma)
for 30 min at 42 C, biotinylated oligonucleotide probes were added
and allowed to hybridize at 42 C overnight. Membranes were then
washed at 42 C in three successive steps of 15 min in respective
solutions of 5, 1 and 0.5 SSC containing 0.1% SDS. Hybridized
probe was detected by a Biodetect detection kit (Beyotime).
2.5. Quantitative RT-PCR
To obtain appropriate cDNA templates for PCR, 2 lg of RNase-
free DNase I (Promega) treated RNA samples were reverse tran-
scribed using Random 9 mers (TaKaRa) or the speciﬁc ysrH gene
primer PLO-246. The PCR was then performed with the oligos
PLO-245/PLO-246 to detect YsrH-speciﬁc RNA transcript. The rela-
tive amount of target mRNA was analyzed by quantitative RT-PCR
(qRT-PCR) using iTaq™ Universal SYBR Green Supermix (Bio-Rad)
following the manufacturer’s instructions.
2.6. Statistical analysis
All results were presented as mean ± standard deviation based
on at least three separate experiments, and the data analyzed using
the student’s t-test.
3. Results
3.1. Expression pattern of YsrH in Y. pseudotuberculosis
The ysrH gene was identiﬁed downstream of the plsX gene on
the minus strand of the chromosome in Y. pestis and this sequence
and arrangement is conserved in other Yersinia species, including Y.
pseudotuberculosis [24]. To test the expression pattern of YsrH in Y.
pseudotuberculosis, RT-PCR was performed with RNA samples iso-
lated from bacteria in different growth phases. We found that YsrH
is already expressed in the early-exponential growth phase and
this expression is maintained at the same level in later stages of
growth with that in the early-exponential growth phase (picture
not shown).
3.2. YsrH inhibits fabH2 mRNA level
Since the ysrH gene is located within the coding region of fabH2,
deletion of ysrHwill also disrupt the expression of fabH2. Hence, to
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constitutive over-expression plasmid named pRO-YsrH by cloning
the ysrH gene downstream of a constitutive PLlacO promoter. This
and the control plasmidwere respectively transformed into Y. pseu-
dotuberculosiswild type strain, and the fabH2mRNA levels in differ-
ent growth phases were analyzed by qRT-PCR. As shown in Fig. 1a,
fabH2 mRNA levels were highest in the early-exponential phase
and then decreased when bacteria were grown to stationary phase.
Over-expression of YsrH severely reduced the fabH2mRNA level by
10-fold at early-exponential phase and repressed7-fold and3-
fold at late-exponential and stationary stage, respectively (Fig. 1a).
As a speciﬁcity control, we also constructed the pRO-YsrHas
plasmid that expresses under the control of the constitutive PLlacO
promoter a RNA product with sequence that is complementary to
YsrH. This antisense product is designed to interfere with endoge-
nously produced YsrH, which would be expected to limit its ability
to base-pair to the fabH2 target mRNA. Indeed, when the anti-YsrH
RNA was expressed in the early-exponential phase, the fabH2
mRNA level was even higher than that in the wild type cells
(Fig. 1a). The most obvious explanation for this is that the inhibi-
tory role of endogenous YsrH is negated by duplex formation
between YsrH and antisense YsrH. Over-expression of anti-YsrH
also de-repressed fabH2 mRNA levels in both late-exponential
and stationary phase (Fig. 1a). These data indicate that the repres-
sive effect of YsrH is speciﬁc.
To further validate the direct regulation of YsrH on fabH2, we
next used qRT-PCR to examine changes to fabH2 mRNA levels in
response to short-term exposure to YsrH. This was achieved byFig. 1. YsrH represses fabH2 mRNA levels. (a) Quantitative RT-PCR analysis of the
regulatory effect that constitutive expression of YsrH (pRO-YsrH) or anti-YsrH
(antisense of YsrH; pRO-YsrHas) has on fabH2 mRNA levels at different growth
phases. The fabH2 mRNA level in control strain was set 1. (b) Quantitative RT-PCR
analysis of the regulatory effect that inducible YsrH has on fabH2 mRNA levels. Y.
pseudotuberculosis carrying pBAD22 control vector or pBAD-YsrH was induced by
0.2% arabinose at an OD600 of 0.5 and samples were collected after cells were
induced for 0, 5 and 10 min, respectively. The fabH2 mRNA level obtained at 0 min
in control strain was set 1. All experiments were performed in triplicate, and the
levels of fabH2 expression in each sample were calculated after normalization to
16S rRNA levels. Error bars represent standard deviation (⁄⁄P < 0.01, ⁄P < 0.05).establishing an inducible YsrH expression system where ysrH
was placed under the control of an arabinose-inducible PBAD pro-
moter. Since we observed that the parental expression level of
YsrH was consistent during the growth stages, and fabH2 mRNA
level reached the peak during the early-exponential phase
(Fig. 1a), we induced YsrH expression in the early-exponential
phase to analyze YsrH-mediated fabH2 mRNA regulation, and the
results showed that YsrH expression was strongly induced by arab-
inose (Fig. S1). Pre-induction of YsrH with 0.2% arabinose at early-
exponential phase for as little as 5 min caused a rapid 34% decrease
of fabH2 mRNA (Fig. 1b). Moreover, a 10 min exposure to YsrH
resulted in even greater repression that was in the vicinity of
75%. In contrast, fabH2 mRNA level was not changed after 10 min
induction in control cells harbouring empty vector (Fig. 1b). Collec-
tively, our data suggest that YsrH is a sRNA that restricts fabH2
mRNA levels by directly duplexing with complimentary sequence
in this speciﬁc target.
3.3. YsrH has no regulatory effect on fabDG in the fabHDG operon
fabH is transcribed in the same operon with fabD and fabG in
E. coli and Salmonella [2,28]. Analysis of the YPIII genome indicates
that this operon architecture is retained in Y. pseudotuberculosis
(data from BIOCYC). To identify whether YsrH also exerts a regula-
tory role on fabD and fabG in Yersinia, we compared mRNA levels of
fabD and fabG in strains constitutively over-expressing YsrH or
anti-YsrH as well as the control strain with the empty vector. With
respect to fabD mRNA levels, no signiﬁcant difference at any phase
of growth was observed among the three different strains (Fig. 2a).
Concerning fabGmRNA levels, a small but signiﬁcant elevation was
observed speciﬁcally in the strain over-expressing anti-YsrH and
grown to early exponential phase, but no signiﬁcant difference was
observed when any of the strains were grown to late-exponential
and stationary phase (Fig. 2b). To further validate these results,
fabD and fabG mRNA levels were analyzed using the arabinose
inducible system. As shown in Fig. 2c, a short burst of YsrH
(5 min) caused an elevation in fabD and fabGmRNA levels whereas
a longer burst (10 min) resulted in signiﬁcant reductions of fabD
and fabGmRNA levels. Given these alterations, and compared with
the regulation effects on fabH2, we suggest that YsrH has no regu-
latory effect on fabD and fabG in the fabHDG operon. Rather, the
dramatic reduction in fabH2mRNA levels caused by YsrH (between
3-fold and 10-fold reduction across the growth curve; see
Fig. 1) leaves no doubt that this particular allele is the bona ﬁde
target of YsrH.
3.4. PNPase inﬂuences YsrH-mediated fabH2 regulation
RNase E is the major endoRNase involved in sRNA-induced
mRNA decay. In particular, the C-terminal scaffold region com-
plexes with Hfq or other proteins to form the RNA degradosome
to participate in the decay of mRNAs targeted by multiple trans-
encoded sRNAs [18,29]. Since YsrH induced the speciﬁc decay of
fabH2 mRNA, the role of RNases in this process was investigated.
The ﬁrst mutant constructed is deﬁcient in RNA degradosome for-
mation because it harbors the rne701 allele encoding a truncated
RNase E unable to bind Hfq, PNPase, RNA helicase B or enolase
[13]. We also constructed three additional mutants lacking the
ability to produce PNPase (Dpnp), RNase II (Drnb) and RNase R
(Drnr), respectively. In all these strains we then over-expressed
YsrH to investigate whether the RNA degradosome or RNases is
involved in YsrH mediated fabH2 regulation. This analysis revealed
two notable observations. Firstly, compared to parental bacteria
the basal fabH2 mRNA levels in the presence of endogenous YsrH
were signiﬁcantly reduced in the rne701 and Dpnp mutants, but
not in the Drnb and Drnr mutants (Fig. 3a). Secondly, trans
Fig. 2. YsrH has no effect on fabDGmRNA expression. Quantitative RT-PCR analysis
of the regulatory effect of YsrH on fabDmRNA (a and c) and fabGmRNA (b and c) at
different growth phases using either the constitutive expression system (a and b) or
in the inducible expression system (c). In a and b, total RNA was prepared from
early-exponential phase (OD600 of 0.4), late-exponential phase (OD600 of 0.9), and
stationary phase (OD600 of 1.1) cells. The fabD and fabG mRNA levels in control
strain were set 1, respectively. In part c, cells harboring pBAD-YsrH or pBAD control
plasmid were treated with 0.2% arabinose at OD600 of 0.5. The fabD and fabG mRNA
level obtained at 0 min in control strain were set 1, respectively. All the
experiments were performed in triplicate, and the levels of fabD and fabG
expression in every sample were calculated after normalization to 16S rRNA levels.
Error bars represent standard deviation (⁄⁄P < 0.01, ⁄P < 0.05).
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Dpnp mutant by 36-fold compared to just 4-fold in parental
bacteria (Fig. 3a). These data suggest that the PNPase plays a major
role in YsrH-mediated regulation of fabH2 mRNA. Given that YsrH
over-expression also suppressed fabH2 mRNA by 8-fold in the
Drnb background, perhaps RNase II could contribute a minor role
in YsrH induced fabH2 mRNA decay.
In parallel, we transformed the plasmid pBAD-YsrH encoding
arabinose inducible YsrH and the control vector pBAD into paren-
tal, rne701, Dpnp, Drnb and Drnr strains and the expression of YsrH
in these strains were detected by Northern blotting (Fig. S2). Again
we used qRT-PCR to compare the fabH2 mRNA levels in the ﬁve
backgrounds. As shown in Fig. 3b, fabH2 mRNA was repressed by
5-fold and 7-fold in the Dpnp background that had expressed
YsrH for 5 and 10 min, respectively. This compared to between2-fold and 3-fold in most other strains except for the rne701
mutant that showed even less fabH2 mRNA repression (Fig. 3b).
However, since the kinetics of mRNA decay in parent, Drnr and
Drnb bacteria were essentially identical, this argues against our
initial suggestion that RNase II is involved in fabH2 mRNA control
(see Fig. 3a). Despite this, both data sets consistently demonstrated
an essential role for PNPase activity in YsrH-induced fabH2 mRNA
destabilization, and that the RNA degradosome is involved in this
regulatory process.3.5. PNPase mediates YsrH decay
Since PNPase contributed to YsrH-mediated fabH2mRNA degra-
dation, we compared the YsrH level in both parental andDpnp bac-
teria. Analysis by RT-PCR revealed relatively constant expression of
endogenous YsrH in parental bacteria at different phases of
growth, but YsrH was slightly elevated in the Dpnp mutant during
exponential growth phase (picture not shown). Furthermore, com-
bining the constitutive ectopic expression system with Northern
blotting revealed that YsrH accumulated during entry into station-
ary phase, but this was much more pronounced in the Dpnp
mutant (Fig. 4a). To better appreciate the basis for YsrH accumula-
tion in the Dpnp mutant, we performed an YsrH stability assay in
the presence of the transcription inhibitor rifampicin, which was
supplemented to growing bacterial cultures after entry into
early-exponential phase. As shown in Fig. 4b, the turnover of YsrH
after rifampicin treatment of parental bacteria was rapid, with lost
signal occurring within 2 min (Fig. 4b). In contrast, YsrH turnover
was delayed in the Dpnp background (Fig. 4b). Additionally, North-
ern blotting revealed that there was one more upper band in the
Dpnp mutant, which was not observed in the wild type (Fig. 4).
This upper band may be the full-length YsrH, which was unstable
in the presence of PNPase and was processed into smaller products
immediately after transcription. Taken together, these results sug-
gest that PNPase contributes to fabH2 control through speciﬁc tar-
geting of YsrH for rapid decay.4. Discussion
The fatty acid biosynthesis pathway has long been targeted for
the development of new antibacterial agents. For example, the
products of fabD, fabG and fabH2 have all been successfully used
as targets for the development of potent antibacterial agents [5].
FabH is a b-ketoacyl-acyl carrier protein synthase III and is respon-
sible for the ﬁrst reaction in fatty acid biosynthesis – an essential
enzymatic reaction in bacteria [5,30]. In E. coli and Salmonella, half
of the fab genes are transcribed in the cluster plsX, fabH, fabD, fabG,
acpP, and fabF [28]. It is not yet clear if these genes are transcribed
as a polycistronic unit or as monocistronic units. It follows that the
molecular mechanism governing fabH2 regulation is still elusive.
Interestingly, similar fab gene clusters are reported in other bacte-
ria [2], suggesting that conserved regulatory mechanisms are pos-
sible. In this study, we demonstrate the regulatory role of a cis-
encoded sRNA, YsrH, on the expression of fabH2.
Loss of FabH results in altered fatty acid compositionwith small-
colony, reduced cell size and slow growth rate phenotypes in E. coli
[30]. To investigate whether over-expression of YsrH alters fatty
acid biosynthesis and composition in Yersinia, we compared the col-
ony phenotype and growth rate between the control and YsrH over-
expressed strains, but no differences were observed (picture not
shown). This may be explained by the fact that there is complemen-
tation pathway(s) for bacterial fatty acid biosynthesis [30].
First identiﬁed in an avirulent Y. pestis strain, the ysrH gene
transcribes divergently from fabH2 and is completely complemen-
tary with the coding region of fabH2 mRNA, and is highly
Fig. 3. Inﬂuence of RNase activity on YsrH-mediated repression of fabH2 expression. Quantitative RT-PCR analysis of down-regulation of fabH2 mRNA upon constitutive
expression of YsrH (a) or induction of YsrH from pBAD-YsrH plasmid (b) in parental, rne701, Dpnp, Drnb and Drnr strains. Cells were grown to OD600 of 0.5, and then either
removed (a) or treated with 0.2% arabinose for 0, 5 or 10 min (b). The levels of fabH2 expression in wild type (WT) and the various RNase mutants were calculated after
normalization to 16S rRNA levels. In panel a, the level of fabH2 mRNA in parental strain and RNase mutants harboring control plasmid was set 1, respectively. In panel b, the
fabH2mRNA levels in parental strain and RNase mutants harboring the YsrH over-expression vector obtained at 0 min were all set to 100%. The experiments were performed
in triplicate. Error bars represent standard deviation (⁄⁄P < 0.01, ⁄P < 0.05).
Fig. 4. The effect of PNPase on YsrH sRNA levels. Northern blotting analysis was
used to determine the expression level and the decay rates of the YsrH sRNA in Y.
pseudotuberculosis parent (WT) and Dpnp strains. (a) RNA was extracted at different
growth phases and Northern hybridization was performed with 50-biotinylated
oligonucleotide probes. (b) Wild type or Dpnp strain harboring pRO-YsrH plasmid
was treated with 500 lg/mL Rifampicin (+Rif), and samples were collected at the
time points indicated. The experiments were performed in duplicate.
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constitutively over-expression of YsrH only has inﬂuence on the
fabH2 mRNA and not mRNA derived from the downstream fabD
or fabG genes. In contrast, inducible expression of YsrH causes
fabH2 mRNA reduction, while a short burst of YsrH increases fabD
and fabG mRNA, whereas a longer exposure to YsrH reduced fabD
and fabG mRNA levels signiﬁcantly (see Figs. 1b and 2c). Due to
the fact that the operon architecture for this biosynthesis pathway
has not been elucidated, one possible explanation of our data is
that fabD and fabG are transcribed from their own promoters or
are co-transcribed with other downstream genes. Combining the
results in Fig. 2, it is possible that YsrH has some indirect regula-
tory effects on fabD and fabG, which worth further investigation.Almost all known cis-encoded antisense RNAs from the bacterial
chromosome seem to affect either translation or mRNA stability of
their target, although the mechanistic details of these regulatory
process are seldom well-deﬁned [15]. In E. coli, the cis-encoded
sRNA GadY positively regulates gadX mRNA level, which is
co-transcribed in an operon with gadW [31]. Despite this, the
full-length gadX–gadW polycistronic mRNA transcript does not
accumulate in bacteria when GadY is over-expressed [31]. In this
case, it is thought that the interaction between GadY and the inter-
genic region of the gadX–gadWmRNA results in directed processing
of this fully complementary RNA duplex by the double-strand
RNA-speciﬁc endoRNase RNase III [31]. However, whether other
RNases participate in the cis-encoded sRNA mediated regulation
remains unknown. We have now demonstrated that at least one
other RNase – the PNPase – can also mediate decay of cis-encoded
sRNA molecules exempliﬁed by our studies of YsrH. Previously,
PNPase has been described as a protector of some trans-encoded
sRNAs in exponentially growing cells [23]. Moreover, trans-encoded
sRNAs in their Hfq-free state are rapidly degraded by PNPase,
particularly in the stationary phase of growth [20]. Clearly there-
fore, PNPase activity plays an integral role in sRNA regulatory
processes. However, the mechanisms by which PNPase activity
impacts on cis-encoded and trans-encoded sRNAs must be further
elucidated in order to better understand these important regulatory
processes.
Regarding trans-encoded sRNA-mediated target mRNA
degradation, RNase E also plays a signiﬁcant role in cleaving
sRNA–mRNA duplexes in a process often involving Hfq [13,17]. In
this context, RNase E is the core component of a large multimeric
complex known as the RNA degradosome [18]. Our results demon-
strate that the C-terminal region of RNase E acting as a scaffold for
RNA degradosome assembly facilitates YsrH-mediated fabH2
mRNA decay when our arabinose induction experimental set-up
was used (see Fig. 3b). This suggests that the RNA degradosome
has a role in YsrH-induced fabH2 mRNA degradation. Given that
PNPase mediates YsrH decay, it is possible that YsrH dependent
regulation on fabH2 mRNA involves a cascade of events.
In conclusion, our study is the ﬁrst to demonstrate that a
cis-encoded antisense sRNA, YsrH, regulates the fatty acid synthe-
sis pathway in bacteria. YsrH operates at the post-transcriptional
level by speciﬁcally targeting fabH2 monocistronic mRNA
1966 P. Lu et al. / FEBS Letters 588 (2014) 1961–1966transcripts for degradation via PNPase- and RNase E-associated
processing pathways.
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